CellRapeutics™ Leukopak from Prostate Cancer Donor (XS-0426-XU287)

Name: CellRapeutics™ Leukopak from Prostate Cancer Donor
SKU: XS-0426-XU287
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product features a concentrated leucocyte population from donors with histologically confirmed prostate adenocarcinoma. The collection captures the systemic immune signatures of the prostatic tumor microenvironment, including potential alterations in regulatory T-cell frequencies and myeloid cell activation states. It is optimized for the discovery of neoantigen-specific TCRs and the study of the immune system's role in prostate cancer progression and metastasis.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Prostate Cancer Donor

Cat. No.
XS-0426-XU287

Donor Age
Senior

Donor Health
Clinically diagnosed with prostate malignancy. The cell population reflects a systemic environment shaped by prostatic oncogenesis, featuring tumor-responsive lymphocyte profiles and specific endocrine-immune interactions.

Ethnicity
Diverse backgrounds available, predominantly African American and Caucasian cohorts.

Anticoagulant
Acid Citrate Dextrose, optimized to preserve the viability of prostate-specific antigen reactive T cells and NK subsets.

Additional Donor Information
Each lot features a Leukopak from donors with confirmed prostate adenocarcinoma. Profiles include PSA levels, Gleason scores, and androgen deprivation therapy status.

Clinical Profile
Gleason score, TNM staging, current PSA levels, and treatment history.

Additional Information

Medication History
Available upon request. Includes history of Androgen Deprivation Therapy, anti-androgens, and documentation of any previous chemotherapy or radiation treatments.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Prostate Cancer Donor, Leukopak, Prostate Cancer

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Prostate Cancer Donor (XS-0426-XU287). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.